Table 1 Baseline patient demographic data
Patient characteristics (n = 217) | Number (%) |
|---|---|
Age (years), median (IQR) | 63.3 (46–76) |
<40 | 48 (22.1) |
40-75 | 110 (50.7) |
>75 | 59 (27.2) |
Gender | |
Male | 133 (61.3) |
Female | 84 (38.7) |
Origin of primary tumor | |
Leukemia | 131 (60.4) |
Lymphoma | 66 (30.4) |
Multiple myeloma | 20 (9.2) |
Core components and scoring of PPI | |
ECOG performance status 0–2 (score 0) | 36 (16.6) |
ECOG performance status 3 (score 2.5) | 58 (26.7) |
ECOG performance status 4 (score 4) | 123 (56.7) |
No dyspnea (score 0) | 91 (41.9) |
Dyspnea at rest (score 3.5) | 126 (58.1) |
No delirium (score 0) | 187 (86.2) |
Delirium present (score 4) | 30 (13.8) |
No edema (score 0) | 168 (77.4) |
Edema present (score 1) | 49 (22.6) |
Oral intake normal (score 0) | 115 (53.0) |
Oral intake reduced but more than one mouthful (score 1) | 87 (40.1) |
Oral intake less than one mouthful (score 2.5) | 15 (6.9) |
Total PPI score, median (IQR) | 7 (4–8.5) |
Components and scoring of GPS | |
CRP >10 (score 1) | 181 (83.4) |
Albumin <3.5 (score 1) | 156 (71.9) |
Total GPS score, median (IQR) | 2 (1–2) |
Core comorbidity and scoring of CCI | |
Myocardial infarction (score 1) | 8 (3.7) |
Congestive heart failure (score 1) | 5 (2.3) |
Cerebral vascular disease (score 1) | 7 (3.2) |
Peptic ulcer (score 1) | 22 (10.1) |
Hepatic disease, mild (score 1) | 32 (14.7) |
Diabetes, mild or moderate, score (1) | 20 (9.2) |
Pulmonary disease, moderate or severe (score 1) | 5 (2.3) |
Connective tissue disease (score 1) | 9 (4.1) |
Diabetes, severe with end-organ damage (score 2) | 24 (11.1) |
Renal disease, moderate or severe (score 2) | 6 (2.8) |
Solid tumor, without metastases (score 2) | 7 (3.2) |
Hepatic disease, moderate or severe (score 3) | 6 (2.8) |
Solid cancer, with metastases (score 6) | 2 (0.9) |
Total CCI score, median (IQR) | 0 (0–2) |
Died before the end of follow up | 204 (94.0) |